Literature DB >> 1263096

Aqueous solubility of 14C-triamcinolone acetonide.

C R Behl, L H Block, M L Borke.   

Abstract

The blue tetrazolium colorimetric assay has often been employed in the analysis of corticosteroids. However, the reaction between blue tetrazolium and corticosteroids partly depends on the apparent pH of the system. In an earlier study of the temperature dependence of the solubility and dissolution of triamcinolone acetonide in aqueous dissolution media (distilled water and 0.2-1.0 M potassium chloride solutions), pH was not considered. To determine the reliability of the data previously reported, the solubility of 14C-triamcinolone acetonide was determined by a radioisotopic method. The results of the analyses, using a liquid scintillation counting system, indicate that the steroid solubility is generally about 20% lower than that reported previously.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1263096     DOI: 10.1002/jps.2600650329

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Comparative study on pharmacokinetics and toxicity of intravitreal and sub-Tenon injection of triamcinolone acetonide in ocular tissues.

Authors:  Yuko Arie; Hiroko Miyai; Ayako Suzuki; Takeshi Okabe; Mitsuyo Takashima; Mayumi Takata; Takashi Kurasawa; Masaki Ito; Reijiro Arakawa; Yuichiro Ogura; Akira Naito
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

2.  Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear.

Authors:  Elisabeth Engleder; Clemens Honeder; Julia Klobasa; Michael Wirth; Christoph Arnoldner; Franz Gabor
Journal:  Int J Pharm       Date:  2014-06-02       Impact factor: 5.875

3.  Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and in vivo evaluation in a rabbit ocular inflammatory model.

Authors:  Mohamed A Safwat; Heba F Mansour; Amal K Hussein; Soha Abdelwahab; Ghareb M Soliman
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.